Rare diseases
Investigational molecules
Locations
Long-term safety and outcomes of repeated rituximab in adults with schizophrenia spectrum disorder
SwedenEvaluating Gradual Interval Extension of Tezepelumab in Drug Combination for Patients with Severe Asthma
The NetherlandsEffect of dexmedetomidine versus remifentanil and sufentanil on recovery and pain after video‑assisted or robot‑assisted lung surgery in adult patients
FrancePostoperative oxaliplatin liver‑directed chemotherapy plus drug combination in patients with resected colorectal liver metastases at high risk of recurrence
FranceEfficacy of Sivelestat in Patients with Septic Coagulopathy: A Phase IIb Randomized Controlled Trial
FranceSafety and Efficacy of AST-004 in Patients with Mild Complicated Traumatic Brain Injury
The NetherlandsPhase I/II Study of ubamatamab plus drug combination in patients with ovarian cancer who have poor response to first‑line chemotherapy
FranceEnoxaparin or drug combination versus no anticoagulant treatment for incidental subsegmental pulmonary embolism in cancer patients
DenmarkEvaluation of zirconium-89 crefmirlimab berdoxam PET imaging for monitoring renal allograft rejection in kidney transplant recipients
The NetherlandsTicagrelor versus placebo to prevent cerebral ischemia in patients with low‑grade aneurysmal subarachnoid hemorrhage
FranceMontelukast Sodium for disease-modifying treatment in patients with mild‑moderate Parkinson’s disease: open‑label phase II extension study
SwedenPrognostic H2[15O] PET Imaging Study in Patients with Coronary Artery Disease Using O15‑Water, Adenosine and Regadenoson
SwedenTell us about your condition – we search every trial in Europe and connect you with the right site.
